| Date | Time | Source | Headline | Symbol | Company |
| 03/01/2013 | 8:49AM | Edgar (US Regulatory) | (25-NSE) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 02/26/2013 | 1:02PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 02/14/2013 | 10:02AM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 02/14/2013 | 10:02AM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 02/14/2013 | 6:08AM | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 02/14/2013 | 6:08AM | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 02/12/2013 | 8:07AM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 02/12/2013 | 8:03AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 02/05/2013 | 9:01AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 01/24/2013 | 3:51PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 01/23/2013 | 5:26PM | Edgar (US Regulatory) | Proxy Statement - Merger or Acquistion (definitive) (defm14a) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 01/14/2013 | 8:06AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 01/14/2013 | 8:06AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 01/08/2013 | 3:33PM | Edgar (US Regulatory) | Definitive Materials Filed by Investment Companies. (497) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 01/08/2013 | 3:33PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 01/08/2013 | 3:33PM | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 01/08/2013 | 1:40PM | Zacks | Repligen, Pfizer Collaborate - Analyst Blog | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 01/07/2013 | 10:24AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 01/07/2013 | 10:24AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 01/04/2013 | 1:16PM | Zacks | BioMimetic's Pipeline Progresses - Analyst Blog | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 01/03/2013 | 5:10PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 01/03/2013 | 5:10PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 01/03/2013 | 5:08PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 01/03/2013 | 5:08PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 01/03/2013 | 9:00AM | Business Wire | BioMimetic Therapeutics, Inc. Initiates Enrollment in Augment™ Chronic Tendinopathy Clinical Trial | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 01/03/2013 | 3:14AM | Zacks | Zacks #1 Rank Additions for Thursday - Tale of the Tape | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 12/26/2012 | 6:03AM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 12/26/2012 | 6:03AM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 12/26/2012 | 6:03AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 12/26/2012 | 6:03AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |